Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

285 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Nanobodies as novel therapeutic agents in envenomation.
Alirahimi E, Kazemi-Lomedasht F, Shahbazzadeh D, Habibi-Anbouhi M, Hosseininejad Chafi M, Sotoudeh N, Ghaderi H, Muyldermans S, Behdani M. Alirahimi E, et al. Among authors: muyldermans s. Biochim Biophys Acta Gen Subj. 2018 Dec;1862(12):2955-2965. doi: 10.1016/j.bbagen.2018.08.019. Epub 2018 Aug 30. Biochim Biophys Acta Gen Subj. 2018. PMID: 30309831 Review.
Nanobodies as novel agents for cancer therapy.
Revets H, De Baetselier P, Muyldermans S. Revets H, et al. Among authors: muyldermans s. Expert Opin Biol Ther. 2005 Jan;5(1):111-24. doi: 10.1517/14712598.5.1.111. Expert Opin Biol Ther. 2005. PMID: 15709914 Review.
Generation and characterization of a functional Nanobody against the vascular endothelial growth factor receptor-2; angiogenesis cell receptor.
Behdani M, Zeinali S, Khanahmad H, Karimipour M, Asadzadeh N, Azadmanesh K, Khabiri A, Schoonooghe S, Habibi Anbouhi M, Hassanzadeh-Ghassabeh G, Muyldermans S. Behdani M, et al. Among authors: muyldermans s. Mol Immunol. 2012 Feb;50(1-2):35-41. doi: 10.1016/j.molimm.2011.11.013. Epub 2011 Dec 29. Mol Immunol. 2012. PMID: 22208996
Development of VEGFR2-specific Nanobody Pseudomonas exotoxin A conjugated to provide efficient inhibition of tumor cell growth.
Behdani M, Zeinali S, Karimipour M, Khanahmad H, Schoonooghe S, Aslemarz A, Seyed N, Moazami-Godarzi R, Baniahmad F, Habibi-Anbouhi M, Hassanzadeh-Ghassabeh G, Muyldermans S. Behdani M, et al. Among authors: muyldermans s. N Biotechnol. 2013 Jan 25;30(2):205-9. doi: 10.1016/j.nbt.2012.09.002. Epub 2012 Sep 29. N Biotechnol. 2013. PMID: 23031816
Nanobodies: natural single-domain antibodies.
Muyldermans S. Muyldermans S. Annu Rev Biochem. 2013;82:775-97. doi: 10.1146/annurev-biochem-063011-092449. Epub 2013 Mar 13. Annu Rev Biochem. 2013. PMID: 23495938 Review.
Nanobodies and their potential applications.
Hassanzadeh-Ghassabeh G, Devoogdt N, De Pauw P, Vincke C, Muyldermans S. Hassanzadeh-Ghassabeh G, et al. Among authors: muyldermans s. Nanomedicine (Lond). 2013 Jun;8(6):1013-26. doi: 10.2217/nnm.13.86. Nanomedicine (Lond). 2013. PMID: 23730699 Free article.
Nanobodies and recombinant binders in cell biology.
Helma J, Cardoso MC, Muyldermans S, Leonhardt H. Helma J, et al. Among authors: muyldermans s. J Cell Biol. 2015 Jun 8;209(5):633-44. doi: 10.1083/jcb.201409074. J Cell Biol. 2015. PMID: 26056137 Free PMC article. Review.
285 results